Financials

News Discussions Technicals Forecast Seasonals

ALTME fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to TME PHARMA operating, investing, and financing activities

ALTME free cash flow for H2 24 is -1.91 M EUR. For 2024, ALTME free cash flow was -4.65 M EUR and operating cash flow was -4.64 M EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—